This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Quidel Corporation At Credit Suisse 2011 Healthcare Conference Call Transcript

Quidel Corporation ( QDEL)

Credit Suisse 2011 Healthcare Conference Call Transcript

November 9, 2011 9:30 AM ET


Doug Bryant - President and CEO



Thanks everybody for joining us here and it is my pleasure as we start the afternoon session on day 1 here to introduce Quidel, I am really glad – and the guests who have joined us is Doug Bryant to give us an overview of the company presentation and then we will move over to the Canyon Room after this for the breakout.

Dough Bryant

Good afternoon. I hope with such a huge audience that I don’t get a little nervous. I thought it was fine. I’ll be making forward-looking statements, of course.

The company has been around actually quite sometime now. We are based in San Diego and have been around since 1979. Introduced our first commercial product in the diagnostics space in 1984 that was actually a pregnancy test that became the basis for many manufacturers’ products that were out there. In other words, we were an OEM manufacturer originally and then we took our own product into the market. Shortly thereafter developed a Strep A test. And then for years we are known as a Rapid point-of-care diagnostic company that supplies easy to use tests, that were performed in physicians’ offices primarily, but also in a hospital lab segment.

In 1989 we began developing products in other areas that were in the life science research tools space mainly, bone health markers and complement pathway markers that are supplied to pharmaceutical companies and other folks that are doing research. In 1999 through collaboration with GlaxoSmithKline we developed the first Flu A/B product, which has had a couple of improvements over the years. And then, sometime after that we actually went public.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs